Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Medication for Opioid Use Disorder Retention With Post-Release Contingency Management

NCT07322588 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT07322588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07322588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Medication for Opioid Use Disorder Retention With Post-Release Contingency Management
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
June 30, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder